BTWC member states will hear evidence of U.S. and Ukrainian violation of Biological and Toxin Weapons Treaty

From Strategic Stability

Report # 136. The USA and Ukraine violate BTWC

September 3, 2022

Briefing of the Chief of Nuclear, Biological, Chemical and Radiological Defence troops of the Russian Federation Lieutenant General Igor Kirillov (Moscow, September 3, 2022):

On the initiative of the Russian Federation, consultative meeting of the member States of the Convention on the Prohibition of Biological and Toxin Weapons (BTWC) will be hosted in the upcoming week regarding non-compliance with the obligations of the USA and Ukraine within the abovementioned international treaty. The event will include presentation of documentary evidence of the violation of the articles I and IV within the convention on their part.

We want the organisations responsible for compliance with the Convention and the international community to pay their attention to various biological hazards.

First, there are currently over 50 Pentagon-controlled biological laboratories modernised with its funds and located in close proximity to the borders of the Russian Federation. In total, according to the Ministry of Foreign Affairs of China, the U.S. Defence Department controls 336 biolaboratories in 30 countries.

Their activities are supplemented by deterioration of the epidemiological situation regarding to the most dangerous and economically significant infections, as well as by appearance of contagious diseases untypical for a certain region.

Since 2010, the territories of the Russian Federation bordering Ukraine have recorded an increase in the incidence of brucellosis, Congo-Crimean fever, West Nile fever and African swine fever, as well as an uncharacteristic expansion of vector ranges.

The Russian Federation, as a responsible party to the BTWC, is fully aware of the full range of threats associated with the possible consequences of its violation during the works performed in Ukrainian biolaboratories.

We have received information about U.S.-sponsored biological research in Ukraine. The decree of the Ministry of Healthcare of Ukraine (February 24, 2022) for emergency destruction of pathogen collections has reinforced our concerns about possible violation of the articles I and IV within the BTWC requirements in the Pentagon-commissioned work. The obtained materials have served as a basis for the Russian Federation’s investigation of U.S. biological activities at the territory of Ukraine.

The research in Ukrainian biolaboratories was carried out in accordance with the Agreement ‘On cooperation in the field of prevention of the spread of pathogens, technologies and knowledge that can be used in the development of biological weapons’ of 2005 between the U.S. military department and the Ministry of Healthcare of Ukraine.

The U.S. has spent over $250 million on biological programs in Ukraine.

The work was coordinated by the Defense Threat Reduction Agency of the U.S. Department of Defense (DTRA), the research was conducted under conditions of secrecy with limited access of Ukrainian professionals to information and premises.

We are currently witnessing a change in the tactics of the U.S. administration in an attempt to withdraw this office, the activities of which have become the subject of an international investigation. According to available information, the functions of the customer of military-biological programs in the Central Asian region have been transferred to civilian specialised organisations, the work of which will be under control of the U.S. Navy, which is the most closed structure.

In addition, the Pentagon intends to transfer unfinished programs in Ukraine as soon as possible to other post-Soviet countries, as well as to Eastern European states (such as Bulgaria, the Czech Republic) and Baltic countries.

The expansion of the network of biolaboratories, which can be used to create and store components of biological weapons, poses a threat to the military security of the Russian Federation. Unlike the nuclear weapons the U.S. deploys on the territory of NATO partner countries, the Alliance’s similar policy in the biological sphere allows it to approach our borders uncontrolled. This is the first issue we would like to emphasise.

Second, the focus of the Pentagon’s work does not correspond to the current problems of public health in Ukraine, the main of which are socially significant diseases: measles, rubella, tuberculosis, AIDS.

At the same time, the customers from the U.S. are interested in a completely different nomenclature: cholera, tularemia, plague, Congo-Crimean fever and hantaviruses. These pathogens were studied as part of the so-called Ukrainian UP and Tap projects. U.S. military biologists are interested because these pathogens have natural foci both in Ukraine and Russia, while their use can be disguised as natural disease outbreaks.

Continue reading